InvestorsHub Logo
Followers 828
Posts 119328
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 1000

Tuesday, 07/07/2015 12:21:53 PM

Tuesday, July 07, 2015 12:21:53 PM

Post# of 2912
Clarification re ENTA’s $30M milestone from ABBV for Japan; from #msg-113442501:

A $30M milestone payment from ABBV for approval of V-Pak in Japan is expected in 4Q15.

The approval in question is the 2-DAA qD regimen of ABT-450/ABT-267 (not Viekira Pak) for GT1b patients. Also, the milestone payment is expected in calendar 4Q15 (which corresponds to ENTA’s FY1Q16).

Note: ENTA had $227M of cash at 3/31/15.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News